BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 30044839)

  • 1. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
    Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
    PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
    Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
    J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis.
    Langerak T; Mumtaz N; Tolk VI; van Gorp ECM; Martina BE; Rockx B; Koopmans MPG
    PLoS Pathog; 2019 Apr; 15(4):e1007640. PubMed ID: 30998804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection.
    Castanha PMS; Nascimento EJM; Braga C; Cordeiro MT; de Carvalho OV; de Mendonça LR; Azevedo EAN; França RFO; Dhalia R; Marques ETA
    J Infect Dis; 2017 Mar; 215(5):781-785. PubMed ID: 28039355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan.
    Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.
    Londono-Renteria B; Troupin A; Cardenas JC; Hall A; Perez OG; Cardenas L; Hartstone-Rose A; Halstead SB; Colpitts TM
    J Gen Virol; 2017 Jul; 98(7):1702-1712. PubMed ID: 28691657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.
    Pantoja P; Pérez-Guzmán EX; Rodríguez IV; White LJ; González O; Serrano C; Giavedoni L; Hodara V; Cruz L; Arana T; Martínez MI; Hassert MA; Brien JD; Pinto AK; de Silva A; Sariol CA
    Nat Commun; 2017 Jun; 8():15674. PubMed ID: 28643775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD14
    Michlmayr D; Andrade P; Gonzalez K; Balmaseda A; Harris E
    Nat Microbiol; 2017 Nov; 2(11):1462-1470. PubMed ID: 28970482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral Load and Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected Patients.
    Terzian ACB; Schanoski AS; Mota MTO; da Silva RA; Estofolete CF; Colombo TE; Rahal P; Hanley KA; Vasilakis N; Kalil J; Nogueira ML
    Clin Infect Dis; 2017 Oct; 65(8):1260-1265. PubMed ID: 29017246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells.
    Asad S; Feitosa-Suntheimer F; Gold A; Londono-Renteria B; Colpitts TM
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal immune enhancement of dengue and Zika virus infection in human skin.
    Castanha PMS; Erdos G; Watkins SC; Falo LD; Marques ETA; Barratt-Boyes SM
    JCI Insight; 2020 Feb; 5(3):. PubMed ID: 31910161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages.
    Zimmerman MG; Quicke KM; O'Neal JT; Arora N; Machiah D; Priyamvada L; Kauffman RC; Register E; Adekunle O; Swieboda D; Johnson EL; Cordes S; Haddad L; Chakraborty R; Coyne CB; Wrammert J; Suthar MS
    Cell Host Microbe; 2018 Nov; 24(5):731-742.e6. PubMed ID: 30439342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.